Study of Survival in Gastric Cancer with Emphasis on Lymph Node Status as an Independent Prognostic Factor

1. Sitarz R, Skierucha M, Mielko J, et al. Gastric cancer: epidemiology, prevention, classification, and treatment. Cancer Manag Res. 2018;10:239-248.10.2147/CMAR.S149619580870929445300Search in Google Scholar

2. Stock M, Otto F. Gene deregulation in gastric cancer. Gene. 2005;360:1-19.10.1016/j.gene.2005.06.02616154715Search in Google Scholar

3. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74-108.10.3322/canjclin.55.2.7415761078Search in Google Scholar

4. Valentini V, Jansen EP, van Grieken NC, et al. Survival after radiotherapy in gastric cancer, systematic review and meta-analysis. Radiother Oncol. 2009;92:176-183.10.1016/j.radonc.2009.06.01419586672Search in Google Scholar

5. Dicken BJ, Bigam DL, Cass C, Mackey JR, Joy AA, Hamilton SM. Gastric adenocarcinoma: review and considerations for future directions. Ann Surg. 2005;241:27-39.10.1097/01.sla.0000149300.28588.23135684315621988Search in Google Scholar

6. Okusa T, Nakane Y, Boku T, et al. Quantitative analysis of nodal involvement with respect to survival rate after curative gastrectomy for carcinoma. Surg Gynecol Obstet. 1990;170:488-494.Search in Google Scholar

7. Hou Y, Wang X, Chen J. Prognostic significance of metastatic lymph node ratio: the lymph node ratio could be a prognostic indicator for patients with gastric cancer. World J Surg Oncol. 2018;16:198.10.1186/s12957-018-1504-5617272730286762Search in Google Scholar

8. Marchet A, Mocellin S, Ambrosi A, et al.The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an Italian multicentric study in 1853 patients. Ann Surg. 2007;245:543-552.10.1097/01.sla.0000250423.43436.e1187703117414602Search in Google Scholar

9. Sobin LHGM, Wittekind CH. 7th Edition International Union Against Cancer (UICC) TNM classification of malignant tumors. USA: Wiley-Lwass; 2010.Search in Google Scholar

10. Chen S, Zhao BW, Li YF, et al. The prognostic value of harvested lymph nodes and the metastatic lymph node ratio for gastric cancer patients: results of a study of 1,101 patients. PLoS One. 2012;7:e49424.10.1371/journal.pone.0049424349953723166665Search in Google Scholar

11. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. 7th Edition AJCC Cancer staging manual. New York: Springer; 2010.Search in Google Scholar

12. Pedrazzani C, Sivins A, Ancans G, et al. Ratio between metastatic and examined lymph nodes (N ratio) may have low clinical utility in gastric cancer patients treated by limited lymphadenectomy: results from a single-center experience of 526 patients. World J Surg. 2010;34:85-91.10.1007/s00268-009-0288-820020295Search in Google Scholar

13. Kim Y, Squires MH, Poultsides GA, et al. Impact of lymph node ratio in selecting patients with resected gastric cancer for adjuvant therapy. Surgery. 2017;162:285-294.10.1016/j.surg.2017.03.023603690328578142Search in Google Scholar

14. Saito H, Osaki T, Murakami D, et al. Effect of age on prognosis in patients with gastric cancer. ANZ Journal of Surgery. 2006;76:458-461.10.1111/j.1445-2197.2006.03756.x16768768Search in Google Scholar

15. Yang D, Hendifar A, Lenz C, et al. Survival of metastatic gastric cancer: Significance of age, sex and race/ethnicity. J Gastrointest Oncol. 2011;2:77-84.Search in Google Scholar

16. Zu H, Wang H, Li C, et al. Clinicopathologic characteristics and prognostic value of various histological types in advanced gastric cancer. Int J Clin Exp Pathol. 2014;7:5692-5700.Search in Google Scholar

17. Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma - 2nd English Edition. Japanese Cancer. 1998;1:10-24.10.1007/PL00011681Search in Google Scholar

18. Fakuda N, Sugiyama Y, Midorikawa A, Mushiake H. Prognostic significance of the metastatic lymph node ratio in gastric cancer patients. World J Surg. 2009;33:2378-2382.10.1007/s00268-009-0205-119760318Search in Google Scholar

19. Bouvier AM, Haas O, Piard F, Roignot P, Bonithon-Kopp C, Faivre J. How many nodes must be examined to accurately stage gastric carcinomas? Results from a population based study. Cancer. 2002;94:2862-2866.10.1002/cncr.1055012115373Search in Google Scholar

20. Smith DD, Schwarz RR, Schwarz RE. Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database. J Clin Oncol. 2005;23:7114-7124.10.1200/JCO.2005.14.62116192595Search in Google Scholar

21. Nitti D, Marchet A, Olivieri M, et al. Ratio between metastatic and examined lymph nodes is an independent prognostic factor after D2 resection for gastric cancer: analysis of a large European monoinstitutional experience. Ann Surg Oncol. 2003;10:1077-1085.10.1245/ASO.2003.03.52014597447Search in Google Scholar

22. Aurello P, Catracchia V, Petrucciani N, et al. What is the role of nodal ratio as a prognostic factor for gastric cancer nowadays? Comparison with new TNM staging system and analysis according to the number of resected nodes. Am Surg. 2013;79:483-491.10.1177/000313481307900523Search in Google Scholar

23. Liu C, Lu P, Lu Y, Xu H, Wang S, Chen J. Clinical implications of metastatic lymph node ratio in gastric cancer. BMC Cancer. 2007;7:200.10.1186/1471-2407-7-200219478117958880Search in Google Scholar

24. Sianesi M, Bezer L, Del Rio P, et al. The node ratio as prognostic factor after curative resection for gastric cancer. J Gastrointest Surg. 2010;14:614-619.10.1007/s11605-009-1142-x20101526Search in Google Scholar